FDA Probes New Cases of Cancer That May Stem From Cancer Cell Therapies
The FDA is investigating whether CAR T-therapies—cell therapies approved for treating advanced cases of blood cancer—are sparking secondary cases of cancer. The agency announced Tuesday that it has received reports…
Read More »